Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10916
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWong, Nicoleen
dc.contributor.authorBlair, Amy Ren
dc.contributor.authorMorahan, Granten
dc.contributor.authorAndrikopoulos, Sofianosen
dc.date.accessioned2015-05-16T00:29:36Z
dc.date.available2015-05-16T00:29:36Z
dc.date.issued2009-11-11en
dc.identifier.citationEndocrinology 2009; 151(1): 96-102en
dc.identifier.govdoc19906813en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10916en
dc.description.abstractThe C57BL/6J (B6J) strain is the most widely used mouse strain in metabolic research. B6J mice produce a truncated form of nicotinamide nucleotide transhydrogenase (NNT), an enzyme that pumps protons across the inner mitochondrial membrane. It has been proposed that this results in B6J mice having reduced insulin secretion and glucose intolerance compared with other strains of mice (e.g. C3H/HeH and DBA/2) that have a full-length NNT. The aim of this study was to determine whether truncated NNT was associated with reduced insulin secretion and glucose intolerance, comparing B6 substrains that differ in having a truncated NNT. C57BL/6N (B6N) mice have wild-type Nnt. We compared Nnt expression and activity levels as well as in vivo insulin secretion and glucose tolerance between these mice and B6J. Body weights and specific fat-pad depot masses were alike and Nnt expression and activity levels were similar between B6N and B6J mice. Glucose-mediated insulin secretion and insulin sensitivity were comparable between the two groups of mice, as were plasma glucose and insulin levels during the oral glucose tolerance test. The presence of a truncated Nnt did not affect insulin secretion or glucose tolerance on the C57BL/6 background. We suggest that low or normal levels of NNT (regardless of truncation) have little effect on insulin secretion. Rather, it is the increase in expression of Nnt that regulates and enhances insulin secretion. Our data confirm that B6J is a reasonable control strain for diabetes research; this is especially important considering that it is the strain commonly used to generate genetically modified animals.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherBlood Glucose.analysis.metabolismen
dc.subject.otherCells, Cultureden
dc.subject.otherDiabetes Mellitus, Experimental.genetics.pathologyen
dc.subject.otherFemaleen
dc.subject.otherGenetic Variation.physiologyen
dc.subject.otherGlucose Intolerance.geneticsen
dc.subject.otherGlucose Tolerance Testen
dc.subject.otherInsulin.blood.secretionen
dc.subject.otherInsulin-Secreting Cells.metabolismen
dc.subject.otherMaleen
dc.subject.otherMiceen
dc.subject.otherMice, Inbred C57BLen
dc.subject.otherMice, Inbred DBAen
dc.subject.otherMice, Transgenicen
dc.subject.otherMutant Proteins.metabolism.physiologyen
dc.subject.otherNADP Transhydrogenases.genetics.metabolism.physiologyen
dc.subject.otherSequence Deletionen
dc.titleThe deletion variant of nicotinamide nucleotide transhydrogenase (Nnt) does not affect insulin secretion or glucose tolerance.en
dc.typeJournal Articleen
dc.identifier.journaltitleEndocrinologyen
dc.identifier.affiliationUniversity of Melbourne, Department of Medicine, Heidelberg Repatriation Hospital, Heidelberg Heights, Victoria 3081, Australiaen
dc.identifier.doi10.1210/en.2009-0887en
dc.description.pages96-102en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/19906813en
dc.type.austinJournal Articleen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.